Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
Kinco Automation (Shanghai) Co.,Ltd
688160
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
HIMS Hims & Hers Health
- 29.720
- -0.090-0.30%
Close Jan 22 16:00 ET
- 29.560
- -0.160-0.54%
Post 20:01 ET
6.49BMarket Cap67.55P/E (TTM)
30.190High28.750Low7.63MVolume29.730Open29.810Pre Close223.87MTurnover4.07%Turnover RatioLossP/E (Static)218.48MShares35.02052wk High14.76P/B5.57BFloat Cap8.50552wk Low--Dividend TTM187.48MShs Float35.020Historical High--Div YieldTTM4.83%Amplitude2.720Historical Low29.351Avg Price1Lot Size
Hims & Hers Health News
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Analysts Conflicted on These Healthcare Names: Atricure (ATRC) and Hims & Hers Health (HIMS)
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Hims & Hers Health Analyst Ratings
Citi Downgrades Hims & Hers Health(HIMS.US) to Sell Rating, Raises Target Price to $25
BTIG Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $35
Needham Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $31
Hims & Hers Health Is Maintained at Buy by Needham
Hims & Hers Health Analyst Ratings
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Truist Financial Issues a Hold Rating on Hims & Hers Health (HIMS)
Hims & Hers Health: Sell Rating Due to Compounding Exemption Risks and Uncertain GLP-1 Contributions
Hims & Hers Health Initiated at Overweight by Morgan Stanley
Hims & Hers Health Analyst Ratings
Morgan Stanley Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $42
Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft
BullnBearTrading
Jan 3 16:30
🚗 Tesla Q4 Dip: Time to Buy , or Is the Risk Too High? 📉